anmelden
FTSE 100
10.816,56
PKT
+68,40
PKT
+0,64
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.02.23 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 06.02.23 | BAT Outperform | Credit Suisse Group | |
| 06.02.23 | Diageo Outperform | Bernstein Research | |
| 03.02.23 | BP Outperform | RBC Capital Markets | |
| 03.02.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 03.02.23 | Shell (ex Royal Dutch Shell) Neutral | Goldman Sachs Group Inc. | |
| 03.02.23 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 02.02.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.02.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 02.02.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.02.23 | Vodafone Group Equal Weight | Barclays Capital | |
| 02.02.23 | Glencore Outperform | Credit Suisse Group | |
| 02.02.23 | Vodafone Group Underperform | Credit Suisse Group | |
| 02.02.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 02.02.23 | GSK Neutral | Credit Suisse Group | |
| 02.02.23 | GSK Hold | Deutsche Bank AG | |
| 02.02.23 | Vodafone Group Buy | Deutsche Bank AG | |
| 02.02.23 | Glencore Buy | Deutsche Bank AG | |
| 02.02.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.02.23 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 01.02.23 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.02.23 | Rio Tinto Underweight | JP Morgan Chase & Co. | |
| 01.02.23 | GSK Hold | Jefferies & Company Inc. | |
| 01.02.23 | Vodafone Group Hold | Jefferies & Company Inc. | |
| 01.02.23 | Glencore Outperform | RBC Capital Markets | |
| 01.02.23 | Vodafone Group Market-Perform | Bernstein Research | |
| 01.02.23 | GSK Sell | UBS AG | |
| 01.02.23 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 01.02.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.02.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.02.23 | Vodafone Group Buy | Deutsche Bank AG | |
| 01.02.23 | Glencore Overweight | JP Morgan Chase & Co. | |
| 31.01.23 | Unilever Outperform | Credit Suisse Group | |
| 31.01.23 | BAT Overweight | JP Morgan Chase & Co. | |
| 31.01.23 | BAT Buy | Jefferies & Company Inc. | |
| 31.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.01.23 | GSK Hold | Deutsche Bank AG | |
| 31.01.23 | Unilever Buy | Deutsche Bank AG | |
| 31.01.23 | Rolls-Royce Neutral | UBS AG | |
| 31.01.23 | RELX Equal Weight | Barclays Capital |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.
